Europe — EMA
Olmesartan Medoxomil/ Amlodipine Zentiva (Olmesartan Medoxomil, Amlodipine)
Olmesartan medoxil, the active ingredient in Olmesartan Medoxomil/ Amlodipine Zentiva, is a angiotensin II receptor blocker presented as a tablet for oral use.
Request sourcing
What is Olmesartan Medoxomil, Amlodipine?
Olmesartan medoxil, the active ingredient in Olmesartan Medoxomil/ Amlodipine Zentiva, is a angiotensin II receptor blocker presented as a tablet for oral use. It treats hypertension, often in combination with a calcium‑channel blocker, and is intended for adult patients. GNH USA supplies Olmesartan Medoxomil/ Amlodipine Zentiva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.
GNH USA supplies Olmesartan Medoxomil/ Amlodipine Zentiva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.
What is Olmesartan Medoxomil, Amlodipine used for?
Olmesartan Medoxil/Amlodipine is indicated for hypertension management, targeting the renin‑angiotensin system and vascular smooth‑muscle tone. - Hypertension: lowers systolic and diastolic blood pressure to reduce cardiovascular risk. - Hypertension with high vascular resistance: provides additional vasodilation through calcium‑channel blockade. - Hypertension in patients who require combination therapy: simplifies treatment by combining two mechanisms of action. - Hypertension in elderly patients: offers effective blood pressure control with a single pill. - Hypertension resistant to monotherapy: improves control when a single agent is insufficient. - Hypertension with accompanying edema risk: amlododipine component mitigates fluid retention.
